Your browser doesn't support javascript.
COVID-19 After Lung Resection in Northern Italy.
Scarci, Marco; Raveglia, Federico; Bortolotti, Luigi; Benvenuti, Mauro; Merlo, Luca; Petrella, Lea; Cardillo, Giuseppe; Rocco, Gaetano.
  • Scarci M; Thoracic Surgery, ASST Monza, Italy. Electronic address: m.scarci@asst-monza.it.
  • Raveglia F; Thoracic Surgery, ASST Santi Paolo e Carlo, Milan, Italy.
  • Bortolotti L; Thoracic Surgery, Humanitas Gavazzeni Bergamo, Italy.
  • Benvenuti M; Thoracic Surgery, ASST Spedali Civili, Brescia, Italy.
  • Merlo L; Department of Statistical Sciences, Sapienza University of Rome, Italy.
  • Petrella L; MEMOTEF Department, Sapienza University of Rome, Italy.
  • Cardillo G; Thoracic Surgery, San Camillo Forlanini Hospital, Rome, Italy.
  • Rocco G; Thoracic Surgery, Memorial Sloan Kettering, Cornell University, New York.
Semin Thorac Cardiovasc Surg ; 34(2): 726-732, 2022.
Artículo en Inglés | MEDLINE | ID: covidwho-1225523
ABSTRACT
We reviewed surgical cases from 4 Thoracic Surgery departments in the Lombardia region of Italy, the area mostly affected by Coronavirus pandemic in Europe, with the aim to describe the impact of COVID-19 on the treatment of thoracic surgical patients. Clinical, radiological and laboratory data from patients who underwent lung resection from December 2019 to March 2020 were retrospectively collected until June 2020. Univariable Cox regression models were estimated to evaluate potential prognostic factors for developing COVID-19 and to investigate postoperative mortality among patients who developed symptomatic COVID-19 infection. We examined data from 107 patients. (74 lobectomies, 32 wedge/segmentectomies and 1 pneumonectomy). Twelve patients developed COVID-19 (Group 1), whereas 95 patients were not infected (Group 2). In Group 1, 6 patients (50%) died from complications related to infection; in Group 2, one patient (1%) died because of non-COVID-19-related causes. Median days from surgery to first symptoms, CT confirmation, clinical confirmation and PCR positivity was 48.1, 54.3, 55.1, and 55.2 respectively. At univariable analysis, DLCO/VA% (P = 0.008), duration of the surgery (P = 0.009), smoking history (pack/year) (P < 0.001), BMI (P< 0.001) and number of segments resected (P = 0.010) were associated with COVID-19 onset. Moreover, CCI (P < 0.001), DLCO/VA% (P = 0.002), cigarette pack/year (P < 0.001), BMI (P < 0.001) and COVID-19 (P < 0.001) were associated with death. Patients who undergo lung resection and then develop symptomatic COVID-19 infection are at higher risk of developing severe respiratory complications and postoperative death. Insidious symptoms' onset may lead to a delay in diagnosis. We suggest two mitigating strategies (1) Improve symptoms surveillance and isolation during recovery period, (2) Be aware of a potential greater risk of developing symptomatic COVID-19 and death correlated with elevated CCI, BMI, smoking history, DLCO/VA%, number of resected segments and duration of surgery.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Revista: Semin Thorac Cardiovasc Surg Asunto de la revista: Angiología / Cardiología Año: 2022 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Límite: Humanos País/Región como asunto: Europa Idioma: Inglés Revista: Semin Thorac Cardiovasc Surg Asunto de la revista: Angiología / Cardiología Año: 2022 Tipo del documento: Artículo